-
Molecular Health receives IVDR certification for MH Guide
Molecular pathology laboratories now benefit from the highest possible diagnostic reliability and quality in the automated interpretation of genetic tumor profiles.
-
Molecular Health and collaborators prove new analytical approach that leverages real-world data to anticipate molecular causation of adverse drug reactions
Molecular Health and collaborators at the University of Florida College of Pharmacy, Takeda Oncology, and thinkQ2 published a triad of articles that describe and prove the concept of a novel systems approach to elucidate molecular mechanisms of drug toxicities using real-world data (RWD).
-
Molecular Health and Gen Era Diagnostics agree to collaborate in the field of precision oncology in Turkey
Molecular Health and the life science company Gen Era Diagnostics have signed a collaboration agreement to optimize the personalized treatment of patients with cancer. For this purpose, Gen Era will provide the MH Guide software platform to twenty laboratories in Turkey to use in the interpretation of tumor data.
-
MH Guide 5.0: Software for therapy planning in precision oncology, now available with a comprehensive update
Molecular Health has launched the latest version of its analysis software MH Guide. This software, which is used by pathology laboratories and molecular tumor boards, now has improved search capabilities to identify patient- relevant clinical studies.
-
Molecular Health and Korean EONE-Diagnomics Genome Center (EDGC) join forces in liquid biopsy-based precision medicine
The collaboration is intended to establish leadership in the fast-growing precision medicine market for liquid biopsy.
-
Molecular Health and Universitätsmedizin Essen [Essen University Hospital] launch collaborative project to improve care for COVID-19 patients
Pioneering project to use clinical data with evidence-based disease model for better diagnosis and therapy in Germany.
-
Konyang University Hospital in South Korea relies on MH Guide for personalized cancer medicine
Konyang University Hospital in Daejeong, South Korea, will rely on MH Guide in the personalized treatment of its cancer patients. This is the result of an agreement between the hospital and Molecular Health.
-
Molecular Health and FALCO biosystems…
…team up to provide genetic analysis services using MH Guide/BRCA and MH Guide/Mendel. MH Guide/BRCA and MH Guide/Mendel will assist doctors and human geneticists in making decisions about gene variant pathogenicity.
-
CENTOGENE and Molecular Health Announce an Exclusive Collaboration With the Aim to Transform the Development of Orphan Drugs
Molecular Health and CENTOGENE announced today that they will collaborate to initiate the Real-life data and Innovative Bioinformatic Algorithms (RIBA) project – starting with Epilepsy as the first indication.
-
Molecular Health announces collaboration with German private insurer HanseMerkur.
The widespread disease of cancer has many manifestations and degrees of severity. Promising progress has…